GARY CLARK to Compassionate Use Trials
This is a "connection" page, showing publications GARY CLARK has written about Compassionate Use Trials.
Connection Strength
0.265
-
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program. Epilepsia. 2023 08; 64(8):e156-e163.
Score: 0.209
-
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. Epilepsia Open. 2024 Oct; 9(5):1816-1825.
Score: 0.056